• Home
  • Contact Us
Patients and CaregiversHealthcare Professionals
  • learn about itp
    • What is ITP?
    • Types of ITP
    • Symptoms & Diagnosis
    • Treatment
      • Anti-D
      • IVIG
      • Steroids
      • Splenectomy
    • ITP Educational Video
  • about
    winrho® SDF
    • Efficacy
    • Duration
    • Convenience
    • Tolerability
    • Viral Safety
    • Common Questions
  • Living with ITP
    • Patient Stories
      • Brad
    • Working With Your Doctor
      • Medications to Avoid
      • When to Call the Doctor
    • Staying Active
      • Choosing Sports
      • Safety Equipment
      • Child Safety
      • Fatigue
    • Special Medical Situations
      • Dental Care
    • Stress
      • Newly Diagnosed and Stressed
      • Explaining ITP to Others
      • Treatment and Work
    • Relationships
      • Support Networks
      • Spouses
      • Children with ITP
      • Siblings
  • insurance
    • Department of Healthcare Economics
    • Reimbursement Hotline
    • Online Insurance Resources
    • Directory of State Insurers
    • Insurance Terms
    • Common Insurance Questions
  • resources
    • Online Resources
    • Baxter Resources
  • news
  • IMPORTANT RISK INFORMATION for WinRho® SDF PRESCRIBING INFORMATION
  • sign up for eupdatesSIGN UP FOR eUPDATES
For more information
1-800-4WINRHO

(1-800-494-6746)
winrho@baxter.com

ITP Educational Video

An insightful video resource you can trust
Click here

ITP Education Kit

Learn more about ITP and WinRho® when you order the ITP Educational Resource Kit
educational patient kit

ITP Juego Educativo

Aprenda más acercade ITP
y WinRho® cuando usted ordena el ITP Juego Educativo de Recurso

Treatment

Your doctor may decide whether or not treatment is necessary, depending upon your symptoms, platelet counts, and other laboratory test results. Patients with chronic ITP may receive different therapies over the course of treatment. No single therapy is right for every patient in all situations.

Children

Initial treatment of children with acute ITP remains a topic of debate among physicians because often the disease resolves without any treatment. Treatment may be necessary to prevent restrictions of physical activity and prevention of excessive bleeding.1

Adults

Approximately half of adults presenting to their physicians with symptoms of ITP have platelet counts below 10,000/mm3, putting them at risk for excessive bleeding. Therefore, adults generally require treatment at the time of diagnosis.1

Always seek the advice of your own physician or other qualified healthcare professional regarding any medical conditions.

Please see the Important Risk Information for WinRho® SDF for more detailed risk information and the Prescribing Information for full prescribing details.

  1. Cines D.B., Blanchette V.S. Immune Thrombocytopenic Purpura. New England Journal of Medicine. 2002; 346(13): 995-1008.
site map | privacy policy | terms and conditions | about Baxter BioScience

Intended for US Audience Only.

Copyright © 2005-2010, Baxter Healthcare Corporation. All rights reserved.
Site Last Updated 05/11/09